Pharmacists are slowly changing the way they deliver their services. Previous professional literature has demonstrated pharmacists' potential through studies of how clinical pharmacists improve care for patients in many settings, especially for diabetes.
More than 86 million Americans over the age of 20 have prediabetes, 29 million Americans are diagnosed with diabetes, and another 8.1 million Americans are living with undiagnosed diabetes.
Pharmacists are much more likely to see prescriptions for sodium-glucose co-transporter 2 (SGLT2) inhibitors than obesity medications, recent prescription data reveal.
Recently, researchers identified 5 predictive factors for weight loss extent in overweight patients with type 2 diabetes.
In addition to weight gain and poor diet quality, eating meals outside the home has been linked with a greater risk of developing type 2 diabetes.
Obese patients who are able to lose 5% of their bodyweight may lower their risk for type 2 diabetes.
From sedentary desk jobs to antipsychotics, the causes of weight gain are unique to each patient. Working together, pharmacists and patients can create a tailored weight loss plan that addresses individual goals and challenges.
